Tech Company Financing Transactions

ACELYRIN Funding Round

ACELYRIN, operating out of Los Angeles, secured $250 million in investment from Matrix Capital Management, Surveyor Capital and Westlake Village BioPartners.

Transaction Overview

Company Name
ACELYRIN
Announced On
11/17/2021
Transaction Type
Venture Equity
Amount
$250,000,000
Round
Series B
Investors

Matrix Capital Management (Lead Investor) (Alan Colowick)

Surveyor Capital (Lead Investor)

Westlake Village BioPartners (Lead Investor) (Sean Harper)

Cowen Capital Partners

Decheng Capital

Marshall Wace

OrbiMed

RTW Investments

Samsara BioCapital

Tybourne Capital Management

venBio

Proceeds Purpose
The proceeds from the Series B financing will be used to fund licensing and acquisition of additional programs, with a focus in immunology, and accelerate the development of izokibep.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
23371 Mulholland Dr. PMB 417 Woodland Hills
Los Angeles, CA 91364
USA
Phone
Undisclosed
Website
www.acelyrin.com
Email Address
[email protected]
Overview
At ACELYRIN, the patient is at the center of our culture and our business. We are guided by our values of courage, compassion, collaboration, innovation, and a sense of urgency.
Profile
ACELYRIN LinkedIn Company Profile
Social Media
ACELYRIN Company Twitter Account
Company News
ACELYRIN News
Facebook
ACELYRIN on Facebook
YouTube
ACELYRIN on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Shao-Lee Lin
  Shao-Lee Lin LinkedIn Profile  Shao-Lee Lin Twitter Account  Shao-Lee Lin News  Shao-Lee Lin on Facebook
Chief Marketing Officer
Paul Peloso
  Paul Peloso LinkedIn Profile  Paul Peloso Twitter Account  Paul Peloso News  Paul Peloso on Facebook
Chief Operating Officer
Melanie Gloria
  Melanie Gloria LinkedIn Profile  Melanie Gloria Twitter Account  Melanie Gloria News  Melanie Gloria on Facebook
President
Robert Carey
  Robert Carey LinkedIn Profile  Robert Carey Twitter Account  Robert Carey News  Robert Carey on Facebook
Vice President
Terry Bevirt
  Terry Bevirt LinkedIn Profile  Terry Bevirt Twitter Account  Terry Bevirt News  Terry Bevirt on Facebook
Vice President
Brian Wiens
  Brian Wiens LinkedIn Profile  Brian Wiens Twitter Account  Brian Wiens News  Brian Wiens on Facebook
VP - Finance
Suzy Buckhalter
  Suzy Buckhalter LinkedIn Profile  Suzy Buckhalter Twitter Account  Suzy Buckhalter News  Suzy Buckhalter on Facebook
VP - Human Resources
Ron Oyston
  Ron Oyston LinkedIn Profile  Ron Oyston Twitter Account  Ron Oyston News  Ron Oyston on Facebook
VP - Manufacturing
Michael Whitmore
  Michael Whitmore LinkedIn Profile  Michael Whitmore Twitter Account  Michael Whitmore News  Michael Whitmore on Facebook
VP - Operations
Sarah Honig
  Sarah Honig LinkedIn Profile  Sarah Honig Twitter Account  Sarah Honig News  Sarah Honig on Facebook
VP - Regulatory Affairs
Marc Kubasak
  Marc Kubasak LinkedIn Profile  Marc Kubasak Twitter Account  Marc Kubasak News  Marc Kubasak on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/17/2021: Intelligo venture capital transaction
Next: 11/17/2021: Steadily venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.